sunitinib,cabozantinib,nivolumab,bempegaldesleukin,aldesleukin
bms,prometheus,exelixis,pfizer,novartis,clinigen,nektar
['sunitinib', 'nivo', 'cabozantinib', 'aldesleukin', 'bempeg', 'nivolumab', 'renal,(-adrenal)']
esmo 2022: bempegaldesleukin plus nivolumab compared to the investigator s choice of sunitinib or cabozantinib in previously untreated advanced renal cell carcinoma results from a phase 3 randomized study - mashupmd 
Business & Finance News Business & Finance News News Political News US & World News Medicine & Surgery.